drugset / Trial / NCT03448536
A Study to Assess Menstrual Cramp Pain Associated With Primary Dysmenorrhea
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to compare the maximum single dose of Aleve® (two tablets, equivalent to 440 mg of naproxen sodium) to the maximum single dose of Tylenol Extra Strength (two caplets, equivalent to 1000 mg of acetaminophen) in the treatment of menstrual pain associated with primary dysmenorrhea.
Timeline
- Start
- 2018-04-05
- Primary completion
- 2018-09-05
- Completion
- 2018-09-05
Outcome
Met primary endpoint
registry analysis (superiority test); Naproxen Sodium vs Acetaminophen; p < 0.001; LS Means Difference 4.31 (95% CI 2.06 to 6.56); ANCOVA NCT03448536 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetaminophen | Small molecule | 1000 mg | Oral |
| Subject | Naproxen | Small molecule | 440 mg | Oral |